Literature DB >> 18263680

Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer.

Felix J F Herth1, Ralf Eberhardt, Mark Krasnik, Armin Ernst.   

Abstract

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) can reliably sample enlarged mediastinal lymph nodes in patients with non-small cell lung cancer (NSCLC), and in practice is mostly used to sample nodes visible on CT or positron emission tomography (PET). Few data are available on the use of endoscopic procedures to stage the mediastinum in clinical stage 1 lung cancer. The aim of the present study was to determine the results of EBUS-TBNA in sampling mediastinal lymph nodes in patients with lung cancer and a radiographically normal mediastinum and no PET activity. From January 2004 to May 2007, patients highly suspicious for NSCLC with CT scans showing no enlarged lymph nodes (no node > 1 cm) and a negative PET finding of the mediastinum underwent EBUS-TBNA. Identifiable lymph nodes at locations 2r, 2L, 4r, 4L, 7, 10r, 10L, 11r, and 11L were aspirated. All patients underwent subsequent surgical staging. Diagnoses based on aspiration results were compared with those based on surgical results. One hundred patients (mean age, 52.4 years; 59 men) were included. After surgery, 97 patients (mean age, 52.9 years; 57 men) had NSCLC confirmed and were included in the analysis. In this group, 156 lymph nodes ranging 5 to 10 mm in size were detected and sampled. Malignancy was detected in nine patients but missed in one patient. Mean diameter of the punctured lymph nodes was 7.9 mm. The sensitivity of EBUS-TBNA for detecting malignancy was 89%, specificity was 100%, and the negative predictive value was 98.9%. No complications occurred. In conclusion, EBUS-TBNA can be used to accurately sample and stage patients with clinical stage 1 lung cancer and no evidence of mediastinal involvement on CT and PET. Potentially operable patients with no signs of mediastinal involvement may benefit from presurgical staging with EBUS-TBNA.

Entities:  

Mesh:

Year:  2008        PMID: 18263680     DOI: 10.1378/chest.07-2535

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  68 in total

1.  Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer.

Authors:  Jessica S Wang Memoli; Ezzat El-Bayoumi; Nicholas J Pastis; Nichole T Tanner; Mario Gomez; J Terrill Huggins; Georgiana Onicescu; Elizabeth Garrett-Mayer; Kent Armeson; Katherine K Taylor; Gerard A Silvestri
Journal:  Chest       Date:  2011-06-02       Impact factor: 9.410

2.  Evidence for Expanding Invasive Mediastinal Staging for Peripheral T1 Lung Tumors.

Authors:  Emily A DuComb; Benjamin A Tonelli; Ya Tuo; Bernard F Cole; Vitor Mori; Jason H T Bates; George R Washko; Raúl San José Estépar; C Matthew Kinsey
Journal:  Chest       Date:  2020-06-26       Impact factor: 9.410

Review 3.  [Rapid on-site evaluation (ROSE) in cytological diagnostics of pulmonary and mediastinal diseases].

Authors:  J Wohlschläger; K Darwiche; S Ting; T Hager; L Freitag; K W Schmid; H Kühl; D Theegarten
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

Review 4.  Convex probe endobronchial ultrasound: applications beyond conventional indications.

Authors:  Peng Li; Wei Zheng; Li Zhao
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

Review 5.  Ultrasound techniques in the evaluation of the mediastinum, part 2: mediastinal lymph node anatomy and diagnostic reach of ultrasound techniques, clinical work up of neoplastic and inflammatory mediastinal lymphadenopathy using ultrasound techniques and how to learn mediastinal endosonography.

Authors:  Christian Jenssen; Jouke Tabe Annema; Paul Clementsen; Xin-Wu Cui; Mathias Maximilian Borst; Christoph Frank Dietrich
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 6.  Evaluation of lymph node metastasis in lung cancer: who is the chief justice?

Authors:  Yang Xia; Bin Zhang; Hao Zhang; Wen Li; Ko-Pen Wang; Huahao Shen
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

7.  Determinants of practice patterns and quality gaps in lung cancer staging and diagnosis.

Authors:  David E Ost; Jiangong Niu; Linda S Elting; Thomas A Buchholz; Sharon H Giordano
Journal:  Chest       Date:  2014-05       Impact factor: 9.410

Review 8.  The power of synergy in the mediastinal staging of lung cancer.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07       Impact factor: 9.236

9.  Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration: results of the AQuIRE Bronchoscopy Registry.

Authors:  David E Ost; Armin Ernst; Xiudong Lei; David Feller-Kopman; George A Eapen; Kevin L Kovitz; Felix J F Herth; Michael Simoff
Journal:  Chest       Date:  2011-06-09       Impact factor: 9.410

10.  Quality gaps and comparative effectiveness in lung cancer staging and diagnosis.

Authors:  David E Ost; Jiangong Niu; Linda S Elting; Thomas A Buchholz; Sharon H Giordano
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.